Skip to main content
Published locations for HCC with Child-Pugh B cirrhosis: Nivolumab a promising first-line systemic treatment option
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
HCC with Child-Pugh B cirrhosis: Nivolumab a promising first-line systemic treatment option
User login
Username
Password
Reset your password
/content/hcc-child-pugh-b-cirrhosis-nivolumab-promising-first-line-systemic-treatment-option
/fedprac/article/255709/hepatocellular-carcinoma/hcc-child-pugh-b-cirrhosis-nivolumab-promising-first